i still think this is a very good way to play the stem cell segment:
(COMTEX) B: CRYO-CELL Achieves Record Monthly Sales for U-Cord(TM) Pr
B: CRYO-CELL Achieves Record Monthly Sales for U-Cord(TM) Preservation Program
CLEARWATER, Fla., Jan 12, 2001 /PRNewswire via COMTEX/ -- Wanda D. Dearth,
President & Chief Operating Officer of CRYO-CELL International, Inc. (Nasdaq:
CCEL), announced today that the Company achieved record sales during December
2000 for the Company's umbilical cord (U-Cord)(TM) stem cell preservation
program. During the month, requests for information increased 25% over November,
and clients who paid to enroll in the U-Cord Program increased almost 15% over
the previous month. Both represent new records for the business. Monthly sales
were approximately $230,000, which compares to $120,650 during December 1999,
representing an increase of over 90%.
Ms. Dearth commented, "The December results are a dramatic way to begin the new
fiscal year. Our growth justifies management's decisions to make significant
investments in ramping up our staff with field-based Clinical Educators. In
addition, 5 new nurses who comprise the Clinical Services department were hired
to implement a 24/7 on-call program. A major investment in capital equipment
including state-of-the-art computers and an integrated phone system are also
scheduled for implementation. These expenditures will delay profitability until
the second or third quarter of the fiscal year. The dramatic increase in
revenues supports the business decisions as financially sound, especially since
January's partial figures represent another successive record increase over the
previous month."
The Company believes that the growth in revenues has positioned CRYO-CELL well
to continue as America's fastest growing U-Cord stem cell preservation firm.
According to Gerald F. Maass, Executive Vice President, "Physician support for
our program continues to increase as a result of the December distribution of
40,000 CD-ROMs to ACOG (American College of Obstetricians and Gynecologists)
members in which CRYO-CELL is the exclusive cord blood preservation program."
More than 25% of U-Cord program participants are a result of OB/GYN or midwife
referrals. The Company has also recently invested in several expectant parent
awareness programs, including national media advertising and new Internet links
with BabyCenter.com, among others.
CRYO-CELL pioneered America's most affordable cord blood stem cell processing
and storage service. The initial fee of $275 includes the specimen collection
kit, processing, testing and first year's storage. The annual storage fee
thereafter is fixed at $50 for specimens already stored. The Company has become
the largest exclusive computerized, robotically operated U-Cord(TM) stem cell
repository, which cryopreserves cord blood only for the potential medical
benefit of newborns and/or their siblings.
Forward-Looking Statement
Statements wherein the terms "believes", "intends", or "expects" as used are
intended to reflect "forward-looking statements" of the Company. The information
contained herein is subject to various risks, uncertainties and other factors
that could cause actual results to differ materially from the results
anticipated in such forward-looking statements or paragraphs. Readers should
carefully review the risk factors described in other documents the Company files
from time to time with the Securities and Exchange Commission, including the
most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any
Current Reports on Form 8-K filed by the Company.
SOURCE CRYO-CELL International, Inc.
CONTACT: Jill Taymans, CFO of CRYO-CELL International, 727-723-0333, o
fax, 727-723-0444
URL: cryo-cell.com
prnewswire.com
(C) 2001 PR Newswire. All rights reserved.
-0-
KEYWORD: Florida
INDUSTRY KEYWORD: MTC
BIO
SUBJECT CODE: SLS
OTC
*** end of story *** |
